Preferred Label : imidazoles;

MeSH definition : Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).;

Wikipedia link : https://en.wikipedia.org/wiki/Imidazoles;

Is substance : O;

Details


Main resources

You can consult :

Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).

https://medqual.fr/images/GP/ATB/2024-IMIDAZOLES.pdf
2024
France
drug information
popular works
imidazoles
imidazole
imidazole

---
http://www.has-sante.fr/portail/jcms/c_1751307/fr/les-medicaments-de-losteoporose
2023
false
true
false
France
French
bone density conservation agents
osteoporosis
treatment outcome
alendronic acid
alendronate
guidelines for drug use
zoledronic acid
administration, oral
risedronic acid
denosumab
Raloxifene Hydrochloride
strontium ranelate
strontium ranelate
teriparatide
teriparatide
spinal fractures
hip fractures
costs and cost analysis
bone density conservation agents
drug costs
bone density
risk
osteoporosis, postmenopausal
adrenal cortex hormones
osteoporosis
osteoporotic fractures
alendronic acid and colecalciferol
drugs, generic
infusions, intravenous
risedronic acid, calcium and colecalciferol, sequential
injections, subcutaneous
raloxifene
algorithms
Adrenocortical steroid therapy
corticosteroid therapy
Risedronic Acid
Denosumab
diphosphonates
imidazoles
organometallic compounds
thiophenes
Zoledronic Acid

---
https://ansm.sante.fr/tableau-atu-rtu/capmatinib-150-mg-et-200-mg-comprimes-pellicules
2021
false
false
false
France
French
Tyrosine Kinase Inhibitors
package leaflet
summary of product characteristics
guidelines for drug use
capmatinib
capmatinib
Product containing precisely capmatinib 150 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely capmatinib 200 milligram/1 each conventional release oral tablet (clinical drug)
administration, oral
adult
carcinoma, non-small-cell lung
capmatinib
proto-oncogene proteins c-met
c-Met Inhibitor
bronchial neoplasms
Locally Advanced Lung Non-Small Cell Carcinoma
Metastatic Lung Non-Small Cell Carcinoma
carcinoma, non-small-cell lung
mutation
MET Exon 14 Mutation
imidazoles
triazines
imidazoles
triazines

---
https://www.has-sante.fr/jcms/p_3265513/fr/isturisa-osilodrostat
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
Osilodrostat
Osilodrostat
osilodrostat
administration, oral
adult
cushing syndrome
Endogenous Cushing Syndrome
evaluation of the transparency committee
imidazoles
pyridines

---
https://www.ema.europa.eu/en/medicines/human/EPAR/isturisa
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Osilodrostat
Osilodrostat
osilodrostat
orphan drug production
adult
cushing syndrome
administration, oral
steroid 11-beta-hydroxylase
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
imidazoles
pyridines
imidazoles
pyridines

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63090616
2020
false
false
false
France
French
package leaflet
summary of product characteristics
administration, intravaginal
antifungal agents
candidiasis, vulvovaginal
sertaconazole nitrate
sertaconazole
sertaconazole
imidazoles
thiophenes

---
https://www.has-sante.fr/jcms/p_3210118/fr/exacor
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
cifenline succinate
administration, oral
recurrence
tachycardia, supraventricular
tachycardia, ventricular
Ventricular Arrhythmia
anti-arrhythmia agents
cibenzoline
guidelines for drug use
evaluation of the transparency committee
cifenline
imidazoles

---
https://www.has-sante.fr/jcms/p_3146424/fr/tafinlar-mekinist
2020
false
false
false
France
BRAF V600E mutation positive
dabrafenib
dabrafenib
treatment outcome
antineoplastic combined chemotherapy protocols
trametinib
antineoplastic agents
protein kinase inhibitors
trametinib
carcinoma, non-small-cell lung
BRAF protein, human
evaluation of the transparency committee
imidazoles
oximes
pyridones
pyrimidinones
proto-oncogene proteins b-raf

---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2019.08256/
2019
false
false
false
false
Switzerland
intestinal diseases
olmesartan
case reports
Adverse reaction caused by olmesartan (disorder)
journal article
celiac disease
angioedema
imidazoles
tetrazoles

---
https://www.has-sante.fr/portail/jcms/c_2967190/fr/tafinlar
2019
true
France
French
administration, oral
insurance, health, reimbursement
dabrafenib
dabrafenib
dabrafenib
adult
melanoma
antineoplastic agents
antineoplastic agents
BRAF protein, human
evaluation of the transparency committee
neoplasm metastasis
treatment outcome
mutation
survival analysis
Unresectable
BRAF V600E Mutation Present
BRAF V600K Mutation Present
imidazoles
oximes
imidazoles
oximes
proto-oncogene proteins b-raf

---
https://www.has-sante.fr/portail/jcms/c_2911595/fr/mekinist-tafinlar
2019
false
true
false
false
France
trametinib
dabrafenib
treatment outcome
melanoma
administration, oral
antineoplastic combined chemotherapy protocols
adult
antineoplastic agents
protein kinase inhibitors
melanoma
BRAF V600 Mutation
evaluation of the transparency committee
pyridones
pyrimidinones
imidazoles
oximes

---
https://www.medg.fr/imidazole
2019
France
teaching material
scientific and technical information
imidazole
imidazole
imidazole
imidazoles

---
https://www.has-sante.fr/portail/jcms/c_2881373/fr/fonx
false
true
false
France
insurance, health, reimbursement
treatment outcome
oxiconazole nitrate
administration, cutaneous
oxiconazole
candidiasis, cutaneous
tinea versicolor
tinea
antifungal agents
evaluation of the transparency committee
oxiconazole
imidazoles

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00346
2018
false
false
false
Canada
French
English
drug information
eluxadoline
imidazoles
phenylalanine

---
https://www.has-sante.fr/portail/jcms/c_2835407/fr/mekinist-tafinlar
https://www.has-sante.fr/portail/jcms/c_2835407/fr/tafinlar-dabrafenib-en-association-a-mekinist-trametinib-inhibiteurs-de-la-proteine-kinase
2018
false
false
false
false
France
French
evaluation of the transparency committee
dabrafenib
dabrafenib
antineoplastic combined chemotherapy protocols
treatment outcome
administration, oral
carcinoma, non-small-cell lung
BRAF V600 Mutation
trametinib
trametinib
antineoplastic agents
antineoplastic agents
protein kinase inhibitors
protein kinase inhibitors
guidelines for drug use
pyridones
pyrimidinones
pyridones
pyrimidinones
imidazoles
oximes
imidazoles
oximes

---
https://www.has-sante.fr/portail/jcms/c_2794991/fr/monazol
2017
false
false
false
France
French
evaluation of the transparency committee
sertaconazole
imidazoles
thiophenes

---
https://www.has-sante.fr/portail/jcms/c_2780980/fr/iclusig
2017
false
false
false
France
French
evaluation of the transparency committee
administration, oral
ponatinib hydrochloride
ponatinib
ponatinib
imidazoles
pyridazines

---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=42484
http://circulaire.legifrance.gouv.fr/pdf/2017/08/cir_42484.pdf
2017
false
false
false
France
French
legislation
insurance, health, reimbursement
hepatitis C, chronic
elbasvir-grazoprevir drug combination
dasabuvir
legislation, drug
antiviral agents
ritonavir
Product containing ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form)
ombitasvir
paritaprevir
direct acting antivirals
daclatasvir
administration, oral
Simeprevir
sofosbuvir-velpatasvir drug combination
ledipasvir, sofosbuvir drug combination
Multidisciplinary care conference (procedure)
Interdisciplinary medical team conference (procedure)
dasabuvir
ombitasvir
paritaprevir
daclatasvir
benzofurans
drug combinations
imidazoles
quinoxalines
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
sulfonamides
uracil
uracil
anilides
macrocyclic compounds

---
https://www.ema.europa.eu/medicines/human/EPAR/Truberzi
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
eluxadoline
imidazoles
drug approval
europe
gastrointestinal agents
gastrointestinal agents
product surveillance, postmarketing
adult
irritable bowel syndrome
diarrhea
administration, oral
tablets
risk assessment
Irritable bowel syndrome with diarrhea (disorder)
aged
drug interactions
pregnancy
breast feeding
receptors, opioid, delta
receptors, opioid, mu
receptors, opioid, kappa
eluxadoline
eluxadoline
imidazoles
phenylalanine

---
https://www.ema.europa.eu/medicines/human/EPAR/Zepatier
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
elbasvir
elbasvir
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
adult
hepatitis C, chronic
antiviral agents
viral vaccines
Hepatitis C virus subtype 1a (organism)
Hepatitis C virus subtype 1b (organism)
Hepatitis C virus genotype 4 (organism)
administration, oral
drug antagonism
drug evaluation, preclinical
NS-5a protein, hepatitis C virus
protease inhibitors
protease inhibitors
NS3 protein, hepatitis C virus
NS4A cofactor peptide, hepatitis C virus
drug therapy, combination
elbasvir-grazoprevir drug combination
elbasvir and grazoprevir
NS-5 protein, hepatitis C virus
quinoxalines
quinoxalines
benzofurans
imidazoles
viral nonstructural proteins
carrier proteins
benzofurans
imidazoles
benzofurans
imidazoles
quinoxalines

---
http://www.has-sante.fr/portail/jcms/c_2633680/fr/antiviraux-d-action-directe
2016
false
false
false
France
French
evaluation of the transparency committee
adult
hepatitis C, chronic
drug therapy, combination
Sofosbuvir
antiviral agents
direct acting antivirals
daclatasvir
Simeprevir
ledipasvir, sofosbuvir drug combination
dasabuvir
drug combinations
ombitasvir
ritonavir
paritaprevir
fibrosis, liver
risk
has patient
hepacivirus
Infections
autoimmune diseases
hepatic fibrosis, nos
fibrosis
hepatitis C virus
human enterovirus 72
hepatitis C, chronic
business
liver cirrhosis
socialism
patients
chronic infectious disease
guideline
antiviral agents
chronic hepatitis, nos
health
case management
hepatitis c virus
hepatitis a virus
dasabuvir
ombitasvir
paritaprevir
daclatasvir
fibrosis
commerce
patients
guideline
benzimidazoles
fluorenes
uridine monophosphate
sulfonamides
uracil
uracil
anilides
carbamates
macrocyclic compounds
imidazoles

---
BCR-ABL Tyrosine Kinase Inhibitors [GLEEVEC (imatinib mesylate), TASIGNA (nilotinib), BOSULIF (bosutinib), SPRYCEL (dasatinib), ICLUSIG (ponatinib hydrochloride)] - Risk of Hepatitis B Reactivation
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58222a-fra.php
2016
false
false
false
Canada
French
English
pharmacovigilance note
fusion proteins, bcr-abl
protein kinase inhibitors
Imatinib Mesylate
risk
hepatitis b virus
imatinib
nilotinib
nilotinib
bosutinib
bosutinib
Dasatinib
dasatinib
ponatinib hydrochloride
ponatinib
Tyrosine Kinase Inhibitor
Hepatitis B reactivation
guidelines for drug use
continuity of patient care
mass screening
hepatitis B
hepatitis B
Tyrosine Kinase Inhibitors
nilotinib
ponatinib
pyrimidines
imidazoles
pyridazines
aniline compounds
nitriles
quinolines

---
http://www.has-sante.fr/portail/jcms/c_2621276/fr/daklinza
2016
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
daclatasvir
daclatasvir
antiviral agents
antiviral agents
drug therapy, combination
hepatitis C, chronic
adult
NS-5a protein, hepatitis C virus
continuity of patient care
insurance, health, reimbursement
Hepatitis C virus genotype 1 (organism)
Hepatitis C virus genotype 3 (organism)
Hepatitis C virus genotype 4 (organism)
daclatasvir
daclatasvir
daclatasvir
NS-5 protein, hepatitis C virus
imidazoles
viral nonstructural proteins
imidazoles

---
http://www.has-sante.fr/portail/jcms/c_2728866/fr/reevaluation-des-antiviraux-d-action-directe-dans-le-traitement-de-l-hepatite-c
2016
false
false
false
France
French
guidelines for drug use
practice guideline
antiviral agents
hepatitis C, chronic
drug evaluation
Sofosbuvir
administration, oral
Simeprevir
direct acting antivirals
daclatasvir
ledipasvir
ledipasvir, sofosbuvir drug combination
drug therapy, combination
ritonavir
ombitasvir
paritaprevir
dasabuvir
drug resistance, viral
drug interactions
treatment outcome
daclatasvir
ombitasvir
paritaprevir
dasabuvir
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
imidazoles
anilides
carbamates
macrocyclic compounds
sulfonamides
uracil
uracil

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-BRAF-en-monotherapie-vemurafenib-dabrafenib-Medicaments-ciblant-BRAF-ou-MEK-en-association-vemurafenib-cobimetinib-dabrafenib-trametinib
2016
false
false
false
France
French
guidelines for drug use
practice guideline
patients guideline
protein kinase inhibitors
protein kinase inhibitors
Drug-Related side effects and adverse reactions
administration, oral
drug interactions
vemurafenib
vemurafenib
antineoplastic combined chemotherapy protocols
vemurafenib
dabrafenib
dabrafenib
dabrafenib
BRAF protein, human
Metastatic Melanoma
melanoma
melanoma
neoplasm metastasis
BRAF Gene Mutation
continuity of patient care
drug monitoring
interdisciplinary communication
protein kinase inhibitors
vemurafenib
dabrafenib
pregnancy
imidazoles
oximes
imidazoles
oximes
proto-oncogene proteins b-raf
imidazoles
oximes
indoles
sulfonamides
indoles
sulfonamides
indoles
sulfonamides
Vemurafenib
Vemurafenib
Vemurafenib

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-BCR-ABL-Imatinib-Dasatinib-Nilotinib-Bosutinib-Ponatinib-Medicament-ciblant-JAK-Ruxolitinib-Anticancereux-par-voie-orale-informer-prevenir-et-gerer-leurs-effets-indesirables
2016
false
false
false
France
French
practice guideline
antineoplastic agents
administration, oral
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
information dissemination
patient education as topic
drug interactions
Dasatinib
Imatinib Mesylate
fusion proteins, bcr-abl
protein kinase inhibitors
dasatinib
imatinib
nilotinib
nilotinib
bosutinib
ponatinib
ruxolitinib
janus kinases
ponatinib
ruxolitinib
bosutinib
continuity of patient care
pregnancy
Tyrosine Kinase Inhibitors
nilotinib
ruxolitinib
aniline compounds
nitriles
quinolines
imidazoles
pyridazines
pyrimidines
pyrazoles

---
http://www.has-sante.fr/portail/jcms/c_2623462/fr/iclusig
2016
false
true
false
France
French
evaluation of the transparency committee
ponatinib hydrochloride
ponatinib
administration, oral
treatment outcome
antineoplastic agents
leukemia, myeloid, accelerated phase
blast crisis
leukemia, myeloid, chronic-phase
leukemia, lymphocytic, acute, L2
protein kinase inhibitors
orphan drug production
insurance, health, reimbursement
protein-tyrosine kinases
Tyrosine Kinase Inhibitors
precursor cell lymphoblastic Leukemia-Lymphoma
ponatinib
imidazoles
pyridazines

---
https://afef.asso.fr/wp-content/uploads/2018/06/VF-INTERACTIF-RECO-VHC-AFEF-v2103.pdf
http://www.infectiologie.com/UserFiles/File/medias/Recos/2015-juin-Recommandations-AFEF-Hepatite-C.pdf
2016
false
false
true
false
France
French
hepatitis C, chronic
practice guideline
severity of illness index
hepatitis C, chronic
antiviral agents
comorbidity
genotype
daclatasvir
ledipasvir
ribavirin
treatment outcome
drug resistance, viral
pregnancy
patient education as topic
liver cirrhosis
liver transplantation
recurrence
renal insufficiency
child
adolescent
drug users
hiv infections
acute disease
Acute hepatitis C
Simeprevir
Sofosbuvir
ledipasvir
ledipasvir, sofosbuvir drug combination
daclatasvir
imidazoles
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate

---
http://www.e-cancer.fr/content/download/126025/1524695/file/Médicaments%20ciblant%20BCR-ABL.pdf
2015
false
false
false
France
French
practice guideline
guidelines for drug use
administration, oral
antineoplastic agents
Drug-Related side effects and adverse reactions
imatinib
dasatinib
nilotinib
nilotinib
bosutinib
bosutinib
ponatinib
ponatinib
protein kinase inhibitors
ruxolitinib
ruxolitinib
janus kinases
information dissemination
continuity of patient care
hospital-physician relations
hospital-patient relations
physician-patient relations
drug interactions
pregnancy
protein-tyrosine kinases
Tyrosine Kinase Inhibitor
Dasatinib
Imatinib Mesylate
Tyrosine Kinase Inhibitors
nilotinib
ruxolitinib
pyrazoles
aniline compounds
nitriles
quinolines
imidazoles
pyridazines

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00180
2015
false
false
false
false
Canada
French
drug information
daclatasvir
Product containing daclatasvir in oral dose form (medicinal product form)
daclatasvir
imidazoles

---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=871681&nom=N-(n-Butyl)imidazole
Canada
toxicological data sheet
imidazoles
imidazole
imidazole

---
https://www.ema.europa.eu/medicines/human/EPAR/Zoledronic-Acid-Accord
2014
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
zoledronic acid
adult
drugs, generic
bone density conservation agents
bone density conservation agents
bone neoplasms
fractures, bone
spinal cord compression
hypercalcemia
infusions, intravenous
neoplasms
aged
drug interactions
renal insufficiency
pregnancy
breast feeding
fertility
drug evaluation, preclinical
diphosphonates
imidazoles
diphosphonates
imidazoles
Zoledronic Acid
Zoledronic Acid

---
http://www.meddispar.fr/Medicaments/INLYTA-1-B-56/(type)/letter/(value)/I/(cip)/3400926648046
2014
false
false
false
France
French
drug information
administration, oral
antineoplastic agents
drug prescriptions
legislation, drug
axitinib
continuity of patient care
imidazoles
indazoles
Axitinib

---
http://www.meddispar.fr/Medicaments/INLYTA-5-B-56/(type)/letter/(value)/I/(cip)/3400926648275
2014
false
false
false
France
French
drug information
administration, oral
drug prescriptions
legislation, drug
axitinib
continuity of patient care
antineoplastic agents
imidazoles
indazoles
Axitinib

---
http://www.meddispar.fr/Medicaments/ACIDE-ZOLEDRONIQUE-TEVA-PHARMA-5-B-1/(type)/letter/(value)/A/(cip)/3400926883775
2014
false
false
false
France
French
drug information
zoledronic acid
soil
soil
diphosphonates
imidazoles
Zoledronic Acid

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=67939209
2014
false
false
false
France
French
summary of product characteristics
package leaflet
axitinib
compression, nos
pill, nos
dandruff
tablets
seborrhea sicca
axitinib
dandruff
imidazoles
indazoles
Axitinib

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=64922489
2014
false
false
false
France
French
summary of product characteristics
package leaflet
tablets
axitinib
compression, nos
axitinib
dandruff
pill, nos
seborrhea sicca
dandruff
imidazoles
indazoles
Axitinib

---
http://www.meddispar.fr/index.php/Medicaments/TAFINLAR-75-B-120/
2014
false
false
false
France
French
drug information
dabrafenib
dabrafenib
administration, oral
legislation, drug
drug prescriptions
continuity of patient care
capsules
imidazoles
oximes

---
https://www.ema.europa.eu/medicines/human/EPAR/Daklinza
2014
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
daclatasvir
daclatasvir
adult
hepatitis C, chronic
antiviral agents
antiviral agents
continuity of patient care
drug therapy, combination
administration, oral
tablets
NS-5 protein, hepatitis C virus
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
daclatasvir
daclatasvir
daclatasvir
viral nonstructural proteins
imidazoles
imidazoles

---
http://www.meddispar.fr/Medicaments/ACIDE-ZOLEDRONIQUE-KABI-4-B-1/(type)/letter/(value)/A/(cip)/3400926699543
2014
false
true
false
France
French
drug information
zoledronic acid
drugs, generic
drug prescriptions
legislation, drug
infusions, intravenous
continuity of patient care
drug monitoring
diphosphonates
imidazoles
Zoledronic Acid

---
https://centres-antipoison.net/wp-content/uploads/2017/08/Imidaclopride_GT_Phytoveille_VF.pdf
2014
false
false
false
France
French
retrospective studies
france
imidacloprid
reports and studies
environmental exposure
accidents, home
suicide, attempted
insecticides
accidents, occupational
gardening
occupational exposure
signs and symptoms
insecticides
imidacloprid
poisoning
occupational exposure
imidazoles
nitro compounds
imidazoles
nitro compounds

---
http://www.meddispar.fr/Medicaments/INLYTA-7-B-56/%28type%29/letter/%28value%29/I/%28cip%29/3400927547669
2014
false
true
false
France
French
drug information
administration, oral
drug prescriptions
legislation, drug
axitinib
continuity of patient care
antineoplastic agents
imidazoles
indazoles
Axitinib

---
http://www.meddispar.fr/Medicaments/INLYTA-3-B-56/%28type%29/letter/%28value%29/I/%28cip%29/3400927547379
2014
false
false
false
France
French
drug information
administration, oral
drug prescriptions
legislation, drug
axitinib
continuity of patient care
antineoplastic agents
imidazoles
indazoles
Axitinib

---
http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Medicaments/INESSS_Portrait_usage_osteoporose.pdf
2014
false
false
false
Canada
French
technical report
adult
aged
diphosphonates
osteoporotic fractures
alendronate
bone density conservation agents
imidazoles
medication adherence
vitamin D
calcium
calcium, dietary
osteoporosis
Risedronic Acid
Denosumab
Zoledronic Acid

---
http://www.has-sante.fr/portail/jcms/c_2009488/fr/daklinza
http://www.has-sante.fr/portail/jcms/c_2009488/fr/daklinza-daclatasvir-antiviral-a-action-directe
2014
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
daclatasvir
daclatasvir
antiviral agents
antiviral agents
drug resistance, viral
drug therapy, combination
hepatitis C, chronic
adult
NS-5a protein, hepatitis C virus
continuity of patient care
insurance, health, reimbursement
guidelines for drug use
daclatasvir
daclatasvir
daclatasvir
NS-5 protein, hepatitis C virus
imidazoles
viral nonstructural proteins
imidazoles

---
http://www.has-sante.fr/portail/jcms/c_1742463/fr/tafinlar
2014
false
France
French
administration, oral
insurance, health, reimbursement
dabrafenib
dabrafenib
dabrafenib
adult
melanoma
antineoplastic agents
antineoplastic agents
BRAF protein, human
evaluation of the transparency committee
neoplasm metastasis
treatment outcome
mutation
survival analysis
Unresectable
BRAF V600E Mutation Present
BRAF V600K Mutation Present
imidazoles
oximes
imidazoles
oximes
proto-oncogene proteins b-raf

---
http://www.lecrat.eu/?s=Fenticonazole
2013
France
French
pregnancy
imidazoles
antifungal agents
fenticonazole
fenticonazole
fenticonazole
imidazoles
drug information

---
http://www.lecrat.eu/?s=Tioconazole
2013
France
French
pregnancy
antifungal agents
imidazoles
tioconazole
tioconazole
tioconazole
imidazoles
drug information

---
http://www.has-sante.fr/portail/jcms/c_1701315/fr/zometa
http://www.has-sante.fr/portail/jcms/c_1701314/fr/zometa06112013avisct12958
http://www.has-sante.fr/portail/jcms/c_981921/fr/zometa
http://www.has-sante.fr/portail/jcms/c_399784/fr/zometa-4-mg-poudre-et-solvant-pour-solution-pour-perfusion-boite-de-1
http://www.has-sante.fr/portail/jcms/c_399290/fr/zometa-4-mg-poudre-et-solvant-pour-solution-pour-perfusion-boite-de-1-4-et-10?xtmc=&xtcr=4
2013
France
French
evaluation of the transparency committee
bone density conservation agents
diphosphonates
imidazoles
zoledronic acid
infusions, intravenous
insurance, health, reimbursement
neoplasms
hypercalcemia
adult
bone neoplasms
bone neoplasms
fractures, spontaneous
spinal cord compression
Zoledronic Acid

---
https://www.ema.europa.eu/medicines/human/EPAR/Zometa
2013
United Kingdom
English
French
syndication feed
drug evaluation
diphosphonates
imidazoles
bone density conservation agents
hypercalcemia
bone neoplasms
treatment outcome
imidazoles
diphosphonates
bone density conservation agents
bone resorption
zoledronic acid
diphosphonates
neoplasms
drug evaluation
summary of product characteristics
package leaflet
fractures, spontaneous
spinal cord compression
hypercalcemia
Zoledronic Acid

---
http://www.cancer-environnement.fr/322-4-methylimidazole-4-MEI.ce.aspx
2012
false
true
false
France
4-methylimidazole
imidazoles
imidazoles
imidazoles
imidazoles
environmental exposure
scientific and technical information

---
http://www.lecrat.eu/?s=Butoconazole
France
French
pregnancy
imidazoles
antifungal agents
butoconazole
butoconazole
imidazoles
drug information

---
http://www.lecrat.eu/?s=Bifonazole
France
French
pregnancy
imidazoles
antifungal agents
bifonazole
bifonazole
imidazoles
drug information

---
http://www.lecrat.eu/?s=Omoconazole
France
French
pregnancy
imidazoles
antifungal agents
omoconazole
omoconazole
omoconazole
omoconazole nitrate
drug information

---
https://www.ema.europa.eu/medicines/human/EPAR/Aclasta
2012
United Kingdom
French
English
syndication feed
diphosphonates
imidazoles
bone density conservation agents
diphosphonates
imidazoles
bone density conservation agents
osteitis deformans
zoledronic acid
diphosphonates
imidazoles
osteoporosis, postmenopausal
osteoporosis
osteoporotic fractures
risk
hip fractures
osteoporosis
drug evaluation
summary of product characteristics
package leaflet
Zoledronic Acid
Zoledronic Acid

---
http://www.lecrat.eu/?s=Sertaconazole
France
French
imidazoles
pregnancy
thiophenes
antifungal agents
sertaconazole
sertaconazole
imidazoles
thiophenes
drug information

---
http://www.lecrat.eu/?s=Oxiconazole
France
French
pregnancy
imidazoles
antifungal agents
oxiconazole
oxiconazole
imidazoles
drug information

---
http://tel.archives-ouvertes.fr/tel-00573124/fr/
2011
false
true
false
p38 Mitogen-Activated protein kinases
dissertations, academic
pharmacology
imidazoles

---
http://www.cochrane.org/fr/CD001715
2011
false
true
false
France
United Kingdom
indoles
imidazoles
treatment outcome
review of literature
french abstract
sertindole
schizophrenia

---
http://www.lecrat.eu/?s=Eprosartan+-+TEVETEN
2011
France
French
teratogens
acrylates
imidazoles
thiophenes
pregnancy
antihypertensive agents
eprosartan
eprosartan
acrylates
imidazoles
thiophenes
angiotensin II type 2 receptor blockers
drug information

---
http://www.lecrat.eu/?s=Olm%C3%A9sartan+-+ALTEIS%C2%AE%2C+OLMETEC%C2%AE
2011
France
French
pregnancy
imidazoles
tetrazoles
angiotensin II type 1 receptor blockers
teratogens
antihypertensive agents
olmesartan
olmesartan medoxomil
imidazoles
tetrazoles
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64380145
2010
France
French
angiotensin II type 1 receptor blockers
antihypertensive agents
tetrazoles
imidazoles
hypertension
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64954736
2010
France
French
amlodipine
tetrazoles
imidazoles
antihypertensive agents
angiotensin II type 1 receptor blockers
hypertension
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65107402
2010
France
French
imidazoles
tetrazoles
angiotensin II type 1 receptor blockers
antihypertensive agents
hypertension
drug information

---
http://unt-ori2.crihan.fr/unspf/2010_Lyon1_Nebois_heterocycliques_aromatiques_monocycliques.pdf
2010
true
false
true
France
educational course
education, pharmacy
chemistry, organic
imidazoles
heterocyclic compounds, 1-ring
pyrroles
pyridines

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64127633
2010
France
French
imidazoles
tetrazoles
angiotensin II type 1 receptor blockers
antihypertensive agents
amlodipine
hypertension
drug information

---
https://www.has-sante.fr/jcms/r_1439939
2008
true
France
French
diphosphonates
imidazoles
bone density conservation agents
osteoporosis, postmenopausal
injections, intravenous
zoledronic acid
guidelines for drug use
Zoledronic Acid
Zoledronic Acid

---
https://cadth.ca/sites/default/files/cdr/complete/cdr_complete_Aclasta_july-08_f.pdf
2008
Canada
French
bone density conservation agents
diphosphonates
imidazoles
osteoporosis, postmenopausal
canada
treatment outcome
osteitis deformans
fractures, bone
infusions, intravenous
insurance, health, reimbursement
drug costs
zoledronic acid
diphosphonates
imidazoles
drug evaluation
Zoledronic Acid

---
http://www.meddispar.fr/medicaments/3658711
2008
France
French
imidazoles
drug prescriptions
legislation, drug
diphosphonates
continuity of patient care
infusions, parenteral
zoledronic acid
drug information
Zoledronic Acid

---
https://minerva-ebp.be/fr/article/588
2007
false
minerva-ebm.be
Belgium
French
osteoporosis, postmenopausal
imidazoles
diphosphonates
imidazoles
diphosphonates
fractures, bone
drug evaluation
diphosphonates
imidazoles
critical appraisal or critical reading
Zoledronic Acid

---
http://www.lecrat.eu/?s=Sulconazole
2006
France
French
antifungal agents
imidazoles
pregnancy
sulconazole
sulconazole
drug information

---
https://www.amub-ulb.be/system/files/rmb/old/216
2005
Belgium
French
osteitis deformans
diphosphonates
imidazoles
bone density conservation agents
diphosphonates
imidazoles
journal article
Zoledronic Acid

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.